🟢 LifeMD is trading 6% up in pre-market

LifeMD is trading at $2.38, up 6.01% in pre-market, with no clear company-specific catalyst identified.

• LifeMD announced after the October 20 close that it will report third-quarter results on November 9; this is a scheduled reporting date, not results or guidance.
• U.S. indices are higher pre-market, but available evidence does not establish that broader-market strength caused LifeMD’s move.